Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 9

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 9
---
 shares are held in “street name” by a bank, brokerage firm or other nominee, please follow the
instructions on the voting instruction card furnished by such bank, brokerage firm or other nominee. Any stockholder of record participating in the Special Meeting may vote even if such stockholder has returned a proxy card. However, if your shares
are held in “street name” you must obtain a legal proxy from the bank, brokerage firm or nominee to vote at the Special Meeting.

Enfusion Stockholders of record as of , 2025 will be able to participate in the Special Meeting by
visiting and entering the -digit control number included on your proxy card or voting instruction card that accompanied your proxy materials.

If you have any questions about the Special Meeting, the Transactions, the proposals or the accompanying Proxy Statement/Prospectus, would
like additional copies of the Proxy Statement/Prospectus, need to obtain proxy cards or other information related to this proxy solicitation or need help submitting a proxy or voting your shares of Enfusion Common Stock or Enfusion Class B
Common Stock, you should contact:

Enfusion, Inc.

125 South Clark Street, Suite 750

Chicago, IL 60603

(312) 253-9800

Attention: Investor Relations

or

Innisfree M&A Incorporated

501 Madison Avenue, 20 Floor

New York City, NY 10022

Banks and
Brokerage Firms Call: (212) 750-5833

Stockholders Call Toll Free: (877) 750-0637

By order of the board of directors

Oleg Movchan

Chief Executive Officer

Dated: , 2025

Chicago,
Illinois

ii

ADDITIONAL INFORMATION This Proxy Statement/Prospectus incorporates important business and financial information about Clearwater and Enfusion from other documents that Clearwater and Enfusion have filed with the U.S. Securities and Exchange Commission (the “ SEC”) and that are contained in or incorporated by reference into this Proxy Statement/Prospectus. For a listing of documents incorporated by reference into this Proxy Statement/Prospectus, please see the section titled “Where You Can Find More Information.” This information is available for you to review on the SEC’s website at www.sec.gov. You can obtain copies of this Proxy Statement/Prospectus and the documents incorporated by reference into this Proxy Statement/Prospectus free of charge by requesting them in writing or by telephone at the following addresses and telephone numbers:

| For